Skip to main content

Table 1 General Characteristics of 197 participants on PI based second line ART regimen

From: Magnitude and correlates of virological failure among adult HIV patients receiving PI based second line ART regimens in north western Tanzania; a case control study

Variable

Frequency

Percent or median (IQR)

Age (years)

197

48 [41–54]

Sex

 Male

51

25.89

 Female

146

74.11

Marital status

 Married

56

28.43

 Divorce

36

18.27

 Widow

64

32.65

 single

40

20.30

WHO stage at ART1

 3&4

114

57.87

 1&2

83

42.13

CD4 at ART1

 Median (cells/μl)

197

295.5 [179–406]

  < 200cells/μl

57

28.93

  ≥ 200 cells/μl

140

71.07

WHO stage at ART2

 3&4

135

68.53

 1&2

62

31.47

CD4 at ART2

 Median (cells/μl)

197

484 [341–700]

  < 200cells/μl

26

13.20

  ≥ 200cells/μl

171

86.80

First line ART months

197

113 [46–133]

Second line ART months

197

14 [13–18]

Adherence < 95%

 Yes

25

12.69

 No

172

87.31

Viral load (copies/μl)

  ≥ 1000

24

12.18

  < 1000

173

87.82

  1. CD4 Cluster of differentiation 4, CD4 at ART1 denotes CD4s at initiation of first line ART, CD4 at ART2 CD4 counts at switch to second line ART, IQR Interquatile range, WHOs World health Organization clinical stage, WHO stage at ART1 denotes WHO clinical stage at initiation of first line ART, WHO stage at ART2 Denotes WHO clinical stage at switch to second line ART
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us